Skip to main content

Table 5 Dosage Details as Recommended for Remission-Maintenance Immunosuppressive Therapy [42, 43, 56, 64]

From: Cerebral involvement in systemic vasculitides

AZA

2 mg/kg oral daily

MTX

20–25 mg oral or parenteral weekly

RTX

500 mg i.v. on day 0 and 14, then every 6 months

Leflunomid

20–30 mg oral daily

MMF

2 g oral daily

  1. Abbreviation: i.v. Intravenous